Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,000
Closed -$1.64M 914
2023
Q4
$1.64M Buy
+23,000
New +$1.6M 0.06% 313
2023
Q1
Sell
-3,800
Closed -$284K 845
2022
Q4
$284K Buy
+3,800
New +$271K 0.01% 647
2017
Q4
Sell
-56,000
Closed -$2.06M 2060
2017
Q3
$2.06M Buy
+56,000
New +$2.26M 0.03% 725
2017
Q1
Sell
-16,000
Closed -$642K 2081
2016
Q4
$642K Hold
16,000
0.01% 1407
2016
Q3
$621K Hold
16,000
0.01% 1294
2016
Q2
$554K Buy
+16,000
New +$554K 0.01% 1490

Other funds holding HOLX

Paloma Partners's HOLX Position: Q4 2024 in Review

Paloma Partners sold out of Hologic (HOLX) in Q4 2024, closing a stake of 7,145 shares — an estimated $582K sold.

Paloma Partners first reported a position in HOLX in Q1 2014 and held it in 30 quarters. The position peaked at $5.85M in Q4 2018. 718 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Paloma Partners reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 7,145 Hologic shares in Q4 2024, an estimated $582K.
  • Paloma Partners first reported a position in Hologic in Q1 2014 and held it in 30 quarters.
  • Paloma Partners's Hologic position peaked at $5.85M in Q4 2018.
  • 718 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.